KRISTEN BOCKENSTEDT: Open Payments
NPI 1275617854 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 21 payments from 9 companies in 2025. Trend: 2023 $290 · 2024 $273 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $145 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $63 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $52 |
| Novo Nordisk Inc | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Dexcom, Inc. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 2 | $12 |
Products named: AIRSUPRA, CAPLYTA, JOURNAVX, Wegovy, REXULTI, Dexcom G6 Transmitter, XHANCE, Ozempic.
Industry payments across IA — which companies pay providers there.
